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ZebraﬁshThe speciﬁcation of an appropriate number of cardiomyocytes from the lateral plate mesoderm requires a
careful balance of both positive and negative regulatory signals. To identify new regulators of cardiac
speciﬁcation, we performed a phenotype-driven ENUmutagenesis forward genetic screen in zebraﬁsh. In our
genetic screen we identiﬁed a zebraﬁsh ctr9 mutant with a dramatic reduction in myocardial cell number as
well as later defects in primitive heart tube elongation and atrioventricular boundary patterning. Ctr9,
together with Paf1, Cdc73, Rtf1 and Leo1, constitute the RNA polymerase II associated protein complex, PAF1.
We demonstrate that the PAF1 complex (PAF1C) is structurally conserved among zebraﬁsh and other
metazoans and that loss of any one of the components of the PAF1C results in abnormal development of the
atrioventricular boundary of the heart. However, Ctr9, Cdc73, Paf1 and Rtf1, but not Leo1, are required for the
speciﬁcation of an appropriate number of cardiomyocytes and elongation of the heart tube. Interestingly, loss
of Rtf1 function produced the most severe defects, resulting in a nearly complete absence of cardiac
precursors. Based on gene expression analyses and transplantation studies, we found that the PAF1C regulates
the developmental potential of the lateral plate mesoderm and is required cell autonomously for the
speciﬁcation of cardiac precursors. Our ﬁndings demonstrate critical but differential requirements for PAF1C
components in zebraﬁsh cardiac speciﬁcation and heart morphogenesis.uth, BSRB 454, Los Angeles, CA
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The speciﬁcation of an appropriate number of cardiac precursors is
essential for the development of a functional heart. In vertebrates, cardiac
progenitor cells are speciﬁed from the lateral plate mesoderm (LPM) to
form a bilaterally symmetric heart ﬁeld. These precursor cells then
migrate medially and fuse at the midline. In zebraﬁsh, the fusion of the
heartﬁeld generates a cone-like structure, which develops into a pulsatile
primitiveheart tubeviaaprocessof cellularmigrationandrearrangement.
The size of the zebraﬁsh heart ﬁeld is regulated by both positive and
negative signals originating in the LPMand surrounding tissues (Chenand
Fishman, 2000; Yelon, 2001; Yelon et al., 2002; Zaffran and Frasch, 2002).
Inductive signals such as gata4/5/6, bmp2b, fgf8, hand2 and nkx2.5 in the
LPM push mesodermal cells toward a cardiac fate (Chen and Fishman,
1996; Holtzinger and Evans, 2007; Marques et al., 2008; Peterkin et al.,
2007; Reifers et al., 2000; Reiter et al., 1999, 2001b; Trinh et al., 2005;
Yelon et al., 2000), while RA signaling negatively regulates cardiac
progenitor production by activating the expression of hoxb5b in the limb
ﬁelds (Waxman et al., 2008). Expression of scl and etsrp in the LPManterior to the heart ﬁeld establishes the anterior boundary of cardiac
progenitors (Schoenebeck et al., 2007), while unknown signals from the
notochord establish the posterior heart ﬁeld boundary (Goldstein and
Fishman, 1998). Precise regulation of the expression of all the factors
involved in speciﬁcation of the heart ﬁeld is vitally important for the
development of a functional heart.
The PAF1 complex (PAF1C) is an RNA Polymerase II-interacting
protein complex required for the development of the heart and other
organs (Akanuma et al., 2007; Nguyen et al., 2010). The PAF1C was
originally identiﬁed in yeast, and consists of ﬁve core proteins: Paf1, Ctr9,
Rtf1, Cdc73, and Leo1. Loss of the PAF1C components Paf1 and Ctr9 in
yeast prevents transcriptional activation of theG1 cyclin CLN2, resulting in
defective cell cycle control and cell growth (Koch et al., 1999). Yeast Paf1,
Ctr9, and Rtf1 are also essential for the Set1-mediated methylation of
histone H3 lysine-4 and Paf1 and Rtf1 are additionally required for
Dot1-mediated histone H3 lysine-79 methylation (Krogan et al., 2003).
Furthermore, Paf1 is necessary for proper poly(A) site utilization of a
subset of yeast genes (Penheiter et al., 2005).
In multicellular organisms, the PAF1C is essential for numerous
signaling pathways and developmental processes. In Arabidopsis, PAF1C
proteins are important regulators of ﬂowering-time. Loss of the
Arabidopsis homologs of Paf1, Ctr9, and Rtf1 results in an early ﬂowering
phenotype because of a reduction in histoneH3 lysine-4 trimethylation at
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et al., 2004). The Rtf1 subunit of the PAF1C also regulates the Notch
signaling pathway in Drosophila and zebraﬁsh (Akanuma et al., 2007;
Tenney et al., 2006). Loss of Rtf1 in zebraﬁsh causes a reduction in the
expression level of Notch-regulated genes in the somites, resulting in
aberrant somitogenesis (Akanuma et al., 2007) and loss of Leo1 in
zebraﬁsh produces defects in atrioventricular boundary and neural crest
development (Nguyen et al., 2010). Interestingly, mutation in zebraﬁsh
cdc73 is able to suppress the defects in erythroid gene transcription
elongationof Transcription Intermediary Factor 1gammamutants, resulting
in a rescue of blood development (Bai et al., 2010). Lastly, Cdc73 has also
been shown to positively regulate the Wnt and Hedgehog signaling
pathways in Drosophila and mammalian cells via direct interactions with
beta-catenin andGli proteins (Mosimannet al., 2006, 2009).However, the
function of each component of the PAF1C has not yet been evaluated
systematically in any animal model.
From our ENU mutagenesis screen for genes affecting cardiovascular
development, we identiﬁed a mutant, LA961, with a severe reduction in
cardiac cell number. Positional cloning of thismutant revealed amutation
in the zebraﬁsh homolog of ctr9, a member of the PAF1C. Key differences
are present in the cardiac phenotypes of ctr9 and leo1mutants, suggesting
distinct requirements for the individual proteins of the PAF1C during
cardiogenesis. Bymorpholino knockdown,we found that Paf1, Cdc73 and
Rtf1, like Ctr9, are important for establishing an appropriate number of
cardiomyocytes and for elongation and patterning of the primitive heart
tube. PAF1C components are not essential for the formation of LPM, but
instead regulate the speciﬁcation of LPM derivatives. Furthermore, by
transplanting Rtf1-deﬁcient cells into wild type embryos, we found that
the PAF1Cplays a cell-intrinsic role in the speciﬁcation of cardiomyocytes.
Materials and methods
Zebraﬁsh and ENU mutagenesis
Zebraﬁsh colonieswere cared for and bred under standard conditions.
Developmental stages of zebraﬁsh embryos were determined using
standard morphological features of ﬁsh raised at 28.5 °C (Westerﬁeld,
2000). ENU mutagenesis of Tg(kdrl:GFP)LA116 male zebraﬁsh was
performed as previously described (Nguyen et al., 2010).
Positional cloning
The LA961 mutation was identiﬁed in the AB background and
heterozygous carriers of this mutation were crossed to the polymorphic
WIK strain for mapping. Embryo lysis and PCR-based bulk segregant
analysis were performed as previously described (Nguyen et al., 2010).
Using the Massachusetts General Hospital microsatellite map, we found
that LA961 was linked to markers Z1239 and Z41496 on chromosome 7.
The markers generated during ﬁne mapping include 1162–5 and 395–1
and their primer sequences are as follows (from 5′ to 3′):
1162–5-F: ACTCCTGTGGGATGTGTGTG;
1162–5-R: CAAATAAATTGTATGGAACCCAAT;
395–1-F: TCAGTTTTGACATTCCTGCATC;
395–1-R: GCTGTGGTTTCATGTTCGTC.
To identify the ctr9LA961 mutation, total RNA was isolated from 1 day
post fertilization (dpf) LA961 mutants using RNA Wiz (Ambion, Austin,
TX) and cDNA was synthesized using the Superscript II Kit (Invitrogen).
cDNA fragments were ampliﬁed with Phusion polymerase (NEB) and
cloned into pCR-Blunt II-TOPO (Invitrogen) for sequencing.
Cardiomyocyte cell counting
Tg(myl7:EGFP) transgenic (Huang et al., 2003) wild type and ctr9LA961
mutant embryos were dissociated in Ca2+-free Ringers solution and ﬂatmounted. Dissociated cardiac cellswere photographed and counted using
a Zeiss Axiovert 200M equipped with a Zeiss Axiocam camera.Constructs and morpholinos
The ctr9WT, ctr9LA961, and leo1 full length cDNAs were ampliﬁed from
1 dpf wild-type embryo cDNA using Phusion polymerase (NEB) and
cloned into pCS2+myc or pCS2+3XFLAG for tagging with the Myc and
FLAG epitopes. Full length cDNA for cdc73, paf1, and rtf1 was ampliﬁed
with KOD polymerase (Novagen) and cloned into pCS2+3XFLAG.
Plasmids were cut with NotI and SP6 RNA polymerase was used to
generate mRNA for injection.
Morpholino oligonucleotides targeting the translation initiation sites
of ctr9, cdc73, paf1, and rtf1 (ctr9MO, cdc73MO, paf1MO, and rtf1MO)
were purchased from Gene Tools, LLC and injected at dosages of 0.75 ng
(for ctr9MO), 2 ng (for cdc73MO), 1.5 ng (for paf1MO) and 0.25 ng (for
rtf1MO). Cdc73MO and paf1MO were coinjected with a p53 morpholino
(4 ng and 6.5 ng, respectively) to prevent non-speciﬁc cell death. The
sequences of the morpholinos used are as follows (from 5′ to 3′):
ctr9MO: GATTTCAATGGATCCCCGAGACATG;
cdc73MO: GAAGAACACTCAACACGTCCGCCAT;
paf1MO: CCTGCGTCTGTATGGTAGGAGCCAT;
rtf1MO: CTTTCCGTTTCTTTACATTCACCAT (Akanuma et al., 2007);
p53 morpholino: GCGCCATTGCTTTGCAAGAATTG
Morpholino efﬁcacywas tested byWestern blotting to detect levels of
PAF1 complex proteins in 1 day old morpholino injected embryo lysates.
Embryos were lysed in Rubinﬁeld's Lysis buffer (20 mM Tris pH 8.0,
140 mMNaCl, 1% Triton X-100, 10% glycerol, 1 mMEGTA, 1.5 mMMgCl2,
1 mMNa3VO4, 50 mMNaF, 1 mMDTT) with protease inhibitors (Roche),
and one embryo equivalent was loaded per lane on an 8% polyacrylamide
gel. Electrophoresed proteins were transferred to a nitrocellulose
membrane. Antibodies against PAF1 complex proteins include anti-Ctr9
(1:2,500, SAB1100738, Sigma), anti-Paf1 (1:10,000, A300-172A, Bethyl
Laboratories, Inc.), anti-Cdc73 (1:5,000, C3620, Sigma), and anti-Rtf1
(1:2,000, ab70690, Abcam). Relative protein levels were determined by
densitometry measurements in Adobe Photoshop CS3 using β-actin
(1:5,000, A1978, Sigma) as a loading control.Whole mount in situ hybridization
Embryos for in situ hybridization were raised in embryo medium
supplemented with 0.2 mM 1-phenyl-2-thiourea to maintain optical
transparency (Westerﬁeld, 2000).Whole-mount in situhybridizationwas
performed as described previously (Chen and Fishman, 1996). The
antisense RNA probes used in this study include cmlc2 (myl7), nkx2.5,
vmhc, amhc (myh6), bmp4, notch1b, tbx2b, tbx20, gata4, gata5, hand2, and
ctr9.Antibody staining
Embryos injected with 200 pg of RNA encodingMyc-tagged zebraﬁsh
ctr9, FLAG-tagged zebraﬁsh cdc73, FLAG-tagged zebraﬁsh paf1, or FLAG-
tagged zebraﬁsh rtf1were ﬁxed in 4% PFA in PBS at 75% epiboly. The ﬁxed
embryoswere incubated in primary antibody (1:50mouse anti-FLAGM2,
F1804, Sigma; 1:50 rabbit anti-Myc, 06–549, Upstate) in blocking solution
(10% goat serum in PBDT) for 2 h at room temperature followed by
detection with ﬂuorescent secondary antibodies (1:200 anti-mouse
IgG1-R, sc-2084, Santa Cruz Biotechnology; 1:200 anti-rabbit IgG-Cy5,
81–6116, Invitrogen). Nuclei were stained with DAPI (Invitrogen) and
embryos were embedded in 1% low-melt agarose and imaged on a Zeiss
LSM510 confocal microscope equipped with a 63X water objective.
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For coimmunoprecipitation analysis, 60 embryos injectedwith tagged
constructs were lysed using Rubinfeld's Lysis Buffer (20 mM Tris pH 8.0,
140 mMNaCl, 1% Triton X-100, 10% glycerol, 1 mMEGTA, 1.5 mMMgCl2,
1 mMNa3VO4, 50 mMNaF, 1 mMDTT) with protease inhibitors (Roche).
Binding of antibody (mouse anti-Myc 9E10, 05–419, Upstate) was
performed overnight on a nutator at 4 °C. Protein G sepharose beads
(17-0618-01, GE Healthcare) were used to pull down bound proteins.
Immunoprecipitated proteins were separated on a 7% polyacrylamide gel
and transferred to anitrocellulosemembrane forWestern analysis.Mouse
anti-FLAG M2 (1:10,000, F1804, Sigma) and rabbit anti-mouse IgG-HRP
(1:20,000, 61–6020, Invitrogen) antibodies were used to detect Flag-
tagged proteins.
Transplantations
For experiments requiring MO treatment Tg(myl7:EGFP) donor
embryos or Tg(myl7:mCherry) recipient embryos were injected with
0.25 ng rtf1MO and 0.5 ng p53MO. Donor cells were drawn into a
glass needle by back pressure and 20–30 cells were transplanted into
high stage recipient embryos at the margin in two locations 90° from
each other. On 1 or 2 dpf recipient embryos were scored for donor cell
contribution to the heart. For imaging, 2 dpf hearts were gently
removed from the embryos and mounted in 1% low melt agarose.
Images were taken using a Zeiss LSM510 confocal microscope.
Results
Identiﬁcation of a novel zebraﬁsh cardiac mutant, LA961
In a screen for zebraﬁsh cardiovascular mutants, we identiﬁed a
novel mutant, LA961, with severe defects in the morphogenesis of theFig. 1.Mutation in zebraﬁsh ctr9 perturbs primitive heart tube elongation and causes a redu
LA961mutant (B) embryos. LA961mutants can be distinguished fromwild type embryos bas
and LA961 mutant embryos analyzed for cmlc2 expression at 24 hpf. Wild type embryos h
cardiomyocytes at the midline (D). (E) Graph of number of GFP-positive cardiomyocytes in
(F) Lateral view of wild type (top) and LA961mutant (bottom) embryos at 35 hpf. (G) Diagr
of Ctr9WT and Ctr9LA961 proteins. Grey regions are predicted tetratricopeptide repeat domaprimitive heart tube. In wild type zebraﬁsh embryos, a beating heart
tube is visible on the left side of the body by 24 h post fertilization
(hpf). At 24 hpf, LA961mutants lack a visible heart tube. Additionally,
LA961 mutants exhibit a slight pericardial edema and an absence of
otoliths (Fig. 1A and B). By 35 hpf, LA961 mutants develop a severely
reduced and dysmorphic heart, a complete lack of pigment cells, and a
downwardly curved body (Fig. 1F), indicating that the LA961 gene
plays a role in multiple developmental processes.
We used the cardiomyocyte marker cmlc2 (also known as myl7) to
further examine the heart phenotype in LA961 and found that these
mutants have cmlc2-expressing cells; however these cardiomyocytes fail
to elongate into a tube by 24 hpf and are instead clustered at the midline
(Fig. 1C andD). The number of cells expressing cmlc2 also appeared lower
in LA961mutants. We directly counted the number of cardiomyocytes in
LA961 at 24 hpf by crossing this mutation into a Tg(myl7:EGFP) genetic
background and recording the number of cells expressing green
ﬂuorescent protein (GFP). We found an average of 134 GFP-positive
cells inwild type embryos at 24 hpf (n=7), whereas LA961mutants only
possessed an average of 70 GFP-positive cells at the same developmental
stage (n=6; p=0.00006; Fig. 1E). This dramatic reduction in myl7:
EGFP-positive cells indicates that the LA961 gene is critical for generating
an appropriate number of cardiomyocytes in addition to its role in the
morphogenesis of the primitive heart tube.
The LA961 locus encodes Ctr9
We mapped the LA961 locus to an 11 centimorgan (cM) region on
chromosome 7. Using custom simple sequence length polymorphism
(SSLP) markers, we reﬁned the LA961 interval and found one marker,
1162–5, located0.1 cMfromthe LA961mutant locus (Fig. 1G). Sequencing
of the genes near this marker identiﬁed a nonsense mutation in the ctr9
gene. Overexpression of wild type ctr9 rescued the LA961 mutant
phenotype (out of 40 injected embryos generated by crossing LA961ction in cardiomyocyte cell number. (A and B) Lateral views of 24 hpf wild type (A) and
ed onmissing otoliths (arrowhead) and pericardial edema (arrow). (C and D)Wild type
ave an elongated primitive heart tube (C), whereas LA961 mutants have a clump of
wild type (WT) and LA961 mutant embryos. Error bars indicate standard deviations.
am of LA961mapping. Estimated genetic distance is in centimorgans (cM). (H) Diagram
ins and black regions are predicted nuclear localization domains.
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type embryos injected with 0.75 ng of a morpholino oligonucleotide
targeting the translation start site of ctr9 (ctr9MO) exhibited phenotypes
identical to those seen in ctr9mutants (n=80) (Supplemental Fig. 1).
Zebraﬁsh Ctr9 contains 3 putative nuclear localization signal (NLS)
domains in its C-terminal tail. The ctr9LA961mutation eliminates the third
and the majority of the second of these NLSs (Fig. 1H). To test if this
mutation results in defective localization of the Ctr9 protein, we tagged
wild type andmutant Ctr9 proteinwith aMyc epitope and overexpressed
these constructs in zebraﬁsh embryos. Interestingly, we found that both
Ctr9WT and Ctr9LA961 localize to the nucleus (Supplemental Fig. 2A and B),
indicating that theﬁnal 2NLSs arenot required for the cellular localization
of Ctr9. However, examination of endogenous ctr9 mRNA levels in
ctr9LA961mutants by in situ hybridization revealed a dramatic reduction in
expression (Supplemental Fig. 2C and D), indicating that ctr9LA961
transcripts are likely unstable and are degraded by cellular nonsense
mediated decaymechanisms. Together these ﬁndings suggest that loss of
functionofCtr9 is causative to the cardiac andpigmentdefectsobserved in
LA961 and that the LA961mutation may be hypomorphic.
The PAF1C is evolutionarily conserved in zebraﬁsh
Ctr9 is a member of the multi-protein PAF1C (also consisting of
Paf1, Rtf1, Cdc73, and Leo1), which was initially identiﬁed in yeast.
PAF1C proteins have been conserved through evolution, and are
present and interact with one another in Drosophila and humans
(Adelman et al., 2006; Kim et al., 2010). We questioned whether the
PAF1Cwas structurally conserved in the zebraﬁsh as well. Members of
the PAF1C are known to localize to the nucleus and interact with RNA
polymerase II (Mueller and Jaehning, 2002; Shi et al., 1997). We haveFig. 2. Zebraﬁsh PAF1C components localize to the nucleus and interact with each other in v
nuclear DAPI staining (blue, A′). (B) Flag-tagged Cdc73 (red) and DAPI staining (blue) coloca
nucleus. (D) Flag-tagged Rtf1 (red) and DAPI staining (blue) colocalize in the nucleus. (E)
shows 1 embryo equivalent of total protein lysate. IP row shows immunoprecipitated protepreviously shown that zebraﬁsh Leo1 exhibits a nuclear localization
(Nguyen et al., 2010). Here we further tested whether the other
zebraﬁsh PAF1 component homologs were present in the same
subcellular compartment. We found that Ctr9, Cdc73, Paf1, and Rtf1
all localized speciﬁcally to the nucleus (Fig. 2A–D). This ﬁnding is
consistent with the localization of the PAF1C in yeast, Drosophila, and
humans (Adelman et al., 2006; Kim et al., 2010; Lin et al., 2007a,b;
Porter et al., 2005), and suggests that all ﬁve members of the putative
zebraﬁsh PAF1C can potentially physically interact.
To determine if the zebraﬁsh PAF1C homologs physically interacted,
we co-expressed different tagged PAF1 components in zebraﬁsh embryos
and performed a coimmunoprecipitation assay. We found that Paf1,
Cdc73, and Leo1 efﬁciently coimmunoprecipitatedwithCtr9, but that Rtf1
did not, despite signiﬁcant levels of expressed protein (Fig. 2E). This
ﬁnding is consistent with previous studies showing that while Rtf1
coimmunoprecipitates with other PAF1 components in yeast, its
interactionwith other PAF1C proteins is comparativelyweaker in animals
(Adelman et al., 2006; Mueller and Jaehning, 2002; Rozenblatt-Rosen
et al., 2005; Yart et al., 2005). This implies that the PAF1C in zebraﬁsh is
similar to that of other animals, consisting of, at a minimum, Ctr9, Paf1,
Cdc73, and Leo1, and that the interactionof Rtf1with this complexmaybe
too weak to detect in a standard coimmunoprecipitation assay.The PAF1C is required for multiple steps of cardiac formation in zebraﬁsh
In addition to the ctr9mutation,we also recently identiﬁed amutation
in the zebraﬁsh leo1 homolog. Interestingly, the speciﬁcation of
cardiomyocytes and heart tube elongation are normal in leo1 mutants
(Nguyen et al., 2010), indicating that loss of different members of theivo. (A–A″) Panel (A″) shows the colocalization of Myc-tagged Ctr9 protein (red, A) and
lize in the nucleus. (C) Flag-tagged Paf1 (red) and DAPI staining (blue) colocalize in the
Flag-Paf1, Flag-Cdc73, and Flag-Leo1 coimmunoprecipitate with Myc-Ctr9. Input row
in from 20 embryo equivalents of total protein lysate.
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development.
Because of the disparate roles played by Ctr9 and Leo1 during early
cardiac development, we investigated the functions of the zebraﬁsh
homologs of the remaining three PAF1C components, Cdc73, Paf1, and
Rtf1. We generated morpholino oligonucleotides targeting the
translation start site of each gene and conﬁrmed their efﬁcacy by
Western blotting (Supplemental Fig. 3). Using these morpholinos, we
found that knockdown of cdc73, paf1, and rtf1 resulted in a reduction
in cardiac tissue like that observed in ctr9 mutants and morphants
(Fig. 3A–E). The loss of cardiac tissuewasmost severe in rtf1morphants,
with most of these embryos completely lacking cardiomyocytes
(Fig. 3E). The reduction in cardiac cell number in ctr9, cdc73, paf1, and
rtf1 morphants suggests that the PAF1C plays a critical role in the
production of an appropriate number of cardiomyocytes.
Although early cardiac development proceeds normally in leo1
mutants, our lab has previously identiﬁed a role for leo1 in the
differentiation of the atrioventricular (AV) boundary. Loss of leo1 results
in a failure to initiate expression of an AV boundary genetic program
including bmp4, versican, notch1b, andwnt2bb (Nguyen et al., 2010).We
examined the differentiation of theAV boundary in embryos deﬁcient in
the other PAF1C components to determine if the PAF1C as awhole plays
a role in this developmental process. By 2 days post fertilization (dpf),
rtf1morphants have no detectable cardiac tissue (data not shown) and
ctr9-, cdc73-, and paf1-deﬁcient embryos have small, dysmorphic hearts.
Like wild type embryos, ctr9-, cdc73-, and paf1-deﬁcient embryos
generate a morphologically distinct ventricle and atrium separated by
an AV canal and express vmhc and amhc in a chamber-speciﬁc manner
(Fig. 4A–H). However, the expression patterns of markers for the AV
boundary are highly abnormal in these embryos. In 2-day-old wild type
embryos, bmp4 and tbx2b are strongly expressed in themyocardial cellsFig. 3. Loss of Ctr9, Cdc73, Paf1, and Rtf1 causes defects in myocardial migration, cardiom
expression in 24 hpf wild type andmorphant embryos. Wild type embryos have an elongated
have a small clump of cardiomyocytes situated at themidline. Rtf1morphants have no detect
and 20S (K–O) stage wild type and morphant embryos. In wild type embryos, myocardial pr
(F and K). In ctr9 morphants (G and L), nkx2.5 expression is reduced and myocardial mig
migration and fusion of the myocardial progenitors, but have relatively normal nkx2.5 expres
display reduced nkx2.5 expression and delayed migration and fusion of the myocardial proat the AV boundary and sinus venosus (Fig. 4I and M). In ctr9-, cdc73-,
and paf1-deﬁcient embryos, expression of bmp4 is not concentrated at
theAV boundary (Fig. 4J–L) and tbx2b is expressed throughout the heart
(Fig. 4N–P), suggesting that the differentiation of the AV boundary is
aberrant in these embryos. In addition, we found that the cardiac
expression of notch1b, which is strongly localized to the endocardial
cells of the AV boundary in wild type embryos, was absent in the hearts
of ctr9-, cdc73-, and paf1-deﬁcient embryos (Fig. 4Q–T).
Taken together, our data show that all PAF1C components, except
for Leo1, are required for establishing appropriate numbers of
cardiomyocytes. This reduction in cardiac cell number has the potential
to induce secondary defects in later aspects of cardiac development, like
the AV boundary gene expression defects present in ctr9-, cdc73-, and
paf1-deﬁcient embryos. However, the AV boundary defects in these
morphants are very similar to those observed in leo1 mutants (Nguyen
et al., 2010), which have a normal number of cardiac cells, suggesting that
allmembers of the zebraﬁsh PAF1Cmay play an essential and speciﬁc role
in the differentiation of the AV boundary myocardium and endocardium.
Loss of PAF1C activity causes defective production and migration of
cardiac progenitors
To better understand the role of the PAF1C in early cardiac
development, we examined the speciﬁcation of myocardial precursor
cells in the LPM during somitogenesis. We analyzed the expression of
nkx2.5, a transcription factor involved in regulating the initiation of the
cardiogenic differentiation program (Chen and Fishman, 1996), which
marks a subset of myocardial progenitors (Schoenebeck et al., 2007).
In wild type embryos, the myocardial precursors are situated in
two bilateral groups at the 16S stage (Fig. 3F). By the 20S stage, the
myocardial cells in wild type embryos have completed their migrationyocyte cell number, and primitive heart tube elongation. (A–E) Dorsal views of cmlc2
primitive heart tube at 24 hpf (A), whereas ctr9 (B), cdc73 (C), and paf1 (D) morphants
able cmlc2 expression at 24 hpf (E). (F–O) Dorsal views of nkx2.5 expression in 16S (F–J)
ogenitors arise in the LPM, migrate towards the midline, and fuse to form a cardiac cone
ration and fusion are delayed. Cdc73 morphants (H and M) also display delays in the
sion levels. Paf1morphants (I and N) and rtf1morphants (J and O), like ctr9morphants,
genitors. Expression of nkx2.5 in rtf1 morphants is barely detectable.
Fig. 4. Ctr9, Cdc73, andPaf1are required forAVboundary speciﬁcation. (A–D)Cardiac expressionofvmhc in48 hpf embryos. Inwild type (A), ctr9LA961mutant (B), cdc73morphant (C), and
paf1morphant (D) embryos, vmhc expression is detected primarily in the ventricle. (E–H) Cardiac expression of amhc in 48 hpf embryos. In wild type (E), ctr9LA961 mutant (F), cdc73
morphant (G), and paf1morphant (H) embryos, amhc expression is detected primarily in the atrium. (I–L) Cardiac expression of bmp4 in 48 hpf embryos. Inwild type embryos (I), bmp4
expression is detected in the myocardium of the ventricle, sinus venosus, and AV boundary (arrow). Ctr9LA961 mutant (J), cdc73morphant (K), and paf1morphant (L) embryos display
ventricular expression of bmp4, but have no discernable AV boundary expression. (M–P) Cardiac expression of tbx2b in 48 hpf embryos. In wild type embryos, tbx2b is expressed
by the myocardium of the AV boundary (arrow, M). Ctr9LA961 mutant (N), cdc73morphant (O), and paf1morphant (P) embryos instead aberrantly express tbx2b throughout the
heart. (Q–T) Cardiac expression of notch1b in 48 hpf embryos.Notch1b is expressed by the AV boundary endocardium inwild type embryos (arrow, Q), but is not expressed in the
hearts of ctr9LA961 mutants (R), cdc73 morphants (S), and paf1 morphants (T).
24 A.D. Langenbacher et al. / Developmental Biology 353 (2011) 19–28to the midline and fused to form the cardiac cone (Fig. 3K). In ctr9 and
paf1 morphants, the expression of nkx2.5 at the 16S stage is slightly
reduced compared towild type embryoswhile the expressionofnkx2.5 in
cdc73morphants is relatively normal (Fig. 3F–I). Embryos lacking activity
of ctr9,paf1, and cdc73have reducedor slightly reducednkx2.5 expression
at the 20S stage, and the myocardial precursors in these embryos have
failed to fully migrate to themidline and fuse to form a cardiac cone (Fig.3L–N).Despite this delay inmigration and fusion, cardiomyocytes in ctr9-,
cdc73-, and paf1-deﬁcient embryos do reach the midline by 24 hpf (Fig.
3B–D). Remarkably, we found that expression of nkx2.5 is barely
detectable in rtf1 morphants throughout somitogenesis (Fig. 3J and O).
These results suggest that the components of the PAF1C, and especially
Rtf1, are required for the initiation of the cardiogenic program and the
timely migration of myocardial precursors to the midline.
25A.D. Langenbacher et al. / Developmental Biology 353 (2011) 19–28The PAF1C regulates the speciﬁcation of cardiomyocytes from the LPM
Because of the profound reduction in cardiac tissue and myocardial
precursors seen in PAF1C morphant embryos, we wondered if the PAF1C
was required for the formation or gene expression of the anterior lateral
plate mesoderm (ALPM), the embryonic origin of cardiomyocytes. To
determine if the ALPM was present in embryos lacking activity of PAF1C
members, we analyzed the expression patterns of several ALPMmarkers.
Weexamined theexpressionofhand2,which is expressed inbothanterior
and posterior compartments of the LPM, and gata4 and gata5, which are
expressed in the ALPMandportions of the endoderm (Angelo et al., 2000;
Reiter et al., 1999, 2001a; Serbedzija et al., 1998; Yelon, 2001; Yelon et al.,
2000). In wild type embryos, hand2, gata4, and gata5 are expressed in the
ALPM at the 16S stage (Fig. 5A,D, and G). These genes are expressed at
similar levels in ctr9 and rtf1 morphant embryos (Fig. 5B,C,E,F,H, and I),
suggesting that the PAF1C is not required for the formation of the ALPM.Fig. 5. The PAF1C is required for the speciﬁcation of cardiomyocytes from the anterior lateral pla
expression in 16S stagewild type andmorphant embryos. Inwild type embryos, expression of han
rtf1 morphants, hand2 (B and C), gata4 (E and F), and gata5 (H and I) are expressed in a doma
cardiomyocyte progenitors in the ALPM (J). Expression of tbx20 is reduced in ctr9morphants (K)We also examined the expression pattern of the transcription
factor tbx20 in ctr9 and rtf1morphant embryos. Expression of tbx20 is
detected in the ALPM at early stages, and becomes restricted to
cardiac progenitors by the 15S stage (Grifﬁn et al., 2000). At the 16S
stage, we found that wild type embryos have strong expression of
tbx20 in cardiac progenitors (Fig. 5J), which occupy a domain of the
ALPM. In contrast, ctr9 and rtf1 morphant embryos have reduced
tbx20 expression (Fig. 5K and L), indicating that despite the presence
of ALPM, these embryos are defective in the process of cardiomyocyte
speciﬁcation. This is also consistent with the reduction in the
expression level of the cardiomyocyte progenitor marker nkx2.5 we
detected in PAF1C-deﬁcient embryos, and suggests that the PAF1C is
essential for the speciﬁcation of cardiac tissue from the ALPM.
To test if the earliest steps in the differentiation of mature
cardiomyocytes require PAF1C function, we examined expression of
cmlc2 at the 16S stage in PAF1C componentmorphants. We found thatte mesoderm. (A–L) Dorsal views of hand2 (A–C), gata4 (D–F), gata5 (G–I), and tbx20 (J–L)
d2 (A), gata4 (D), and gata5 (G) is detected in the anterior lateral platemesoderm. In ctr9 and
in similar to that of wild type embryos. (J–L) In wild type embryos, tbx20 is expressed by
and strongly reduced in rtf1morphants (L) at the 16S stage.
26 A.D. Langenbacher et al. / Developmental Biology 353 (2011) 19–28cmlc2 expression has initiated in wild type embryos at 16S, but does
not initiate in rtf1 morphants (Supplemental Fig. 4K–N). In embryos
injected with a combination of ctr9, cdc73, and paf1 morpholinos, we
noted a signiﬁcant delay in the initiation of cmlc2 expression
(Supplemental Fig. 4E and O). This indicates that in addition to the
role of Rtf1 in generating cardiac progenitors, Rtf1 and other PAF1C
components (excluding Leo1) are essential for the initial expressionof the
mature cardiomyocyte marker cmlc2. These data suggest that the PAF1C
may be essential for two distinct phases of cardiac development: cardiac
progenitor cell speciﬁcation and the differentiation of mature
cardiomyocytes.
The role of Rtf1 in cardiac speciﬁcation is cell autonomous
The heart ﬁeld is patterned by signals originating both inside the LPM
and in neighboring tissues (Chen and Fishman, 2000; Yelon, 2001; Yelon
et al., 2002; Zaffran and Frasch, 2002), and therefore the activity of the
PAF1C may be required in a cell intrinsic or extrinsic manner for the
speciﬁcation of cardiac cells. To determine in which tissue(s) the activity
of the PAF1C is required we transplanted cells from rtf1 morphant
embryos intowild type embryos and vice versa and analyzed the ability of
the donor cells to contribute to the myocardium. In order to differentiate
between cardiomyocytes descended from donor or host cells, we
transplanted cells from Tg(myl7:EGFP) transgenic donors in which
cardiomyocytes express GFP (green) into Tg(myl7:mCherry) transgenic
host embryos in which cardiomyocytes express the red ﬂuorescent
protein mCherry. As a control, we ﬁrst transplanted cells from wild type
donor embryos to wild type recipients. When cells are transplanted from
onewild type embryo to another, they robustly contribute to the heart in
51%(73/144)of recipient embryos (Fig. 6AandD). Transplantedwild type
cells were frequently found in clusters and were fully functional and
integrated into the heart, displaying normalmorphology and contractility
(Fig. 6A and data not shown).
On the contrary, we found that rtf1morphant cells did not contribute
to the heart at a high frequency when transplanted into wild type hosts.
Donor rtf1 morphant cells were found in only 8% (11/133) of recipient
hearts (Fig. 6D), and unlike transplanted wild type cells, rtf1 morphant
cardiomyocytes were small and dysmorphic and did not appear to
contract (Fig. 6B and data not shown). When visualized using confocal
microscopy, it is apparent that these morphant cells are only loosely
associated with the periphery of the myocardial layer and do not fullyFig. 6. Rtf1 regulates cardiomyocyte speciﬁcation cell autonomously. (A–C) Confocal projecti
donor cells contribute robustly to the heart when transplanted into wild type recipients (A
type recipient (B). Wild type cells are also able to generate myocardial tissue when trans
experiments showing the contribution of donor cells to the myocardium of recipient embrintegrate into the heart (Supplemental Video 1). While this data shows
that the activity of the PAF1C is required within potential myocardial
precursors for their entry into the cardiogenic program, its activity may
also be required in surrounding tissues. To test this we performed a
reverse transplantationexperiment, placing cells fromawild typeembryo
into an rtf1morphant host. We found that although rtf1morphants lack
hearts at 2 dpf, wild type donor cells were able to form myocardium in
44% (68/154) of rtf1morphant recipients (Fig. 6D). Remarkably, wild type
donor cells in 15 of these rtf1 morphant recipient embryos clustered to
form a small beating heart-like structure. Taken together, our transplan-
tation data suggest that PAF1C activity is required cell autonomously for
the speciﬁcation ofmyocardial progenitors, and that activity of the PAF1C
in tissues surrounding themyocardium likely plays a lesser role in cardiac
speciﬁcation.
Discussion
The PAF1C is an RNA polymerase II-associated protein complex
consisting of ﬁve proteins: Ctr9, Cdc73, Paf1, Rtf1, and Leo1. Genetic
studies have revealed a requirement for the PAF1C in multiple biological
processes including cell cycle regulation, somite and neural crest
development, and maintenance of stem cell pluripotency (Akanuma
et al., 2007; Ding et al., 2009; Koch et al., 1999; Nguyen et al., 2010). Here
we show that the PAF1C is essential formultiple steps in the development
of the heart. All PAF1C proteins are critical for speciﬁcation of the
atrioventricular boundary of the heart, and Ctr9, Cdc73, Paf1, and Rtf1 are
required for establishing an appropriate number of cardiomyocyte
precursors by promoting the speciﬁcation of cardiac cells from the
ALPM (Fig. 7A). By transplanting cells between wild type and rtf1
morphant embryos, we found that Rtf1 functions in a cell autonomous
manner. Transplanted wild type cells were capable of organizing into a
beating structure in rtf1 morphants, whereas rtf1-deﬁcient cells fail to
incorporate into the myocardial layer when transplanted into wild type
hosts. Our ﬁndings establish the PAF1C as a key regulator of cardiac cell
fate.
We found that PAF1Cactivity is dispensable for formationof theALPM,
but is required for determining the cardiogenic potential of the ALPM,
likely via regulation of the expression of a set of cardiac determinants
including nkx2.5 and tbx20. Previous studies in yeast, plants, ﬂies and
human cells have indicated critical roles of this complex in chromatin
remodeling, transcription elongation and mRNA 3′-end formation (Kimons showing a ventral view of the heart in two day-old transplanted embryos. Wild type
), while rtf1 morphant cells exhibit limited contribution when transplanted into a wild
planted into an rtf1 morphant host. (D) Summary of the results from transplantation
yos.
Fig. 7. Diagram of zebraﬁsh PAF1C form and function. (A) Cardiomyocyte progenitors
(red) are derived from the anterior lateral plate mesoderm (ALPM, blue). The ALPM
expresses markers including hand2, gata4, and gata5. The PAF1C is required for the
speciﬁcation of nkx2.5+/tbx20+ cardiomyocyte progenitors from the ALPM. (B) The
PAF1C in zebraﬁsh consists of at least 4 strongly interacting proteins: Ctr9, Paf1, Leo1,
and Ctr9. Based on the phenotypic similarities between embryos lacking Rtf1 and other
PAF1C components, we hypothesize that Rtf1 associates with the zebraﬁsh PAF1C,
albeit less strongly, as has been suggested in other studies on metazoans.
27A.D. Langenbacher et al. / Developmental Biology 353 (2011) 19–28et al., 2010; Krogan et al., 2003; Oh et al., 2004; Penheiter et al., 2005;
Tenney et al., 2006; Zhang et al., 2009). Thus the PAF1Cmay regulate the
transcription of target cardiac genes by inﬂuencing histonemodiﬁcations
or control the elongation and stability of cardiac gene transcripts. It is not
yet known which cardiogenic determinants are directly regulated by
PAF1C activity. This study paves the way for future examination of the
direct binding and epigenetic effects of the PAF1C at cardiac gene
promoters.
The reduction in cardiac cell number varied between ctr9, cdc73, paf1,
and rtf1 morphants, with the most severe defect in cardiomyocyte
speciﬁcation being observed in rtf1 morphants, which usually produced
no cardiomyocytes. Based on Western analysis, Rtf1 protein was almost
completely absent in rtf1 morphants, whereas low levels of targeted
proteins still existed in ctr9, cdc73 and paf1 morphants. This, along with
the ﬁnding that cardiac progenitor cell speciﬁcation was sensitive to the
dosage of Rtf1 suggest that the variation in cardiac speciﬁcation defects
observed among PAF1C component morphants may reﬂect different
efﬁcacies of themorpholinos used in our study. Creatingmutant embryos
lacking both maternal and zygotic messages of PAF1C should provide
further insights into the effect of complete loss of PAF1C function on
cardiac development. Alternatively, the distinct cardiac phenotypes
observed among PAF1C component morphants and mutants may be
indicative of disparate roles of PAF1C proteins in heart development.
Interestingly, simultaneous knockdown of ctr9, paf1, and cdc73 with the
morpholino dosages used in our study induced a signiﬁcantly weaker
phenotype than that seen in rtf1 morphants. We have also previously
shown that leo1 mutants generate a normal number of cardiomyocytes
(Nguyen et al., 2010). These data argue in favor of the possibility that Rtf1
may play a unique role in cardiac development.In yeast, Ctr9, Cdc73, Paf1, Rtf1 and Leo1 form a stable complex
(Mueller and Jaehning, 2002). Our biochemical study shows that
zebraﬁsh Cdc73, Paf1, and Leo1, but not Rtf1, coimmunoprecipitate
with Ctr9. While it is possible that Rtf1 is not a component of the PAF1C
in zebraﬁsh, the abundant phenotypic similarities between rtf1
morphants and embryos deﬁcient in other PAF1C proteins lead us to
hypothesize that Rtf1 is an integral component of the PAF1C but its
interaction with other members of PAF1C is too weak to detect by
coimmunoprecipitation (Fig. 7B). This hypothesis is consistent with
earlier reports that Rtf1 fails to coimmunoprecipitate with the
Drosophila and human PAF1Cs (Adelman et al., 2006; Kim et al., 2010;
Rozenblatt-Rosen et al., 2005). Our ﬁndings suggest that a looser
association between Rtf1 and other PAF1C members is a feature that
may be conserved universally among metazoans.
Our analysis of the zebraﬁsh PAF1C reveals that while all complex
members are required in the speciﬁcation of the atrioventricular
boundary, individual PAF1C components have disparate roles in early
cardiogenesis. Loss of each PAF1C member, excluding Leo1, causes a
reduction in the number of cardiomyocytes speciﬁed from the LPM
(Nguyen et al., 2010). The mechanisms responsible for differing roles
of individual PAF1C components are not yet known. One potential
explanation is that losing individual PAF1C components may have
different effects on overall complex stability. Recent studies indicate
that loss of human Paf1 or Ctr9, but not Leo1, destabilizes the
interactions between other PAF1C members (Kim et al., 2010). This
suggests that Paf1 and Ctr9may serve as a scaffold for the formation of
the PAF1C, and that loss of these proteins disrupts the stability of the
complex as a whole. This idea is consistent with the severe defects in
cardiogenesis noted in ctr9 and paf1morphants compared to the later,
mild cardiac defects noted in leo1 mutants. Another plausible
explanation is that each PAF1C member mediates speciﬁc protein–
protein interactions. Indeed, individual PAF1C members have been
shown to interact with a number of different proteins involved in
transcription regulation. For example, yeast Paf1 interacts directly
with Bre1, linking the PAF1C to histone ubiquitination machinery
(Kim and Roeder, 2009). Yeast Rtf1 directly interactswith the chromatin
remodeling protein Chd1 (Simic et al., 2003). In mammalian cells, PAF1C
interacts with the Wnt and Hh signaling pathways by the direct
association of Cdc73 with beta-catenin and Gli proteins (Mosimann
et al., 2006, 2009). Therefore, the speciﬁc effects on development we
noted upon loss of individual PAF1C components could be a result of loss
of interactionwith particular genes and signaling pathways important for
cardiogenesis. Further studies that map out all the interacting partners
and target genes of the PAF1Cwill be needed to uncover themechanisms
by which this complex regulates speciﬁc signaling pathways and
developmental processes in vertebrates.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.02.011.
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